The Enterprise Value as of December 2024 (TTM) for Compass Therapeutics, Inc. (CMPX) is 176.46M

According to Compass Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 176.46M. This represents a change of -4.72% compared to the average of 185.19M of the last 4 quarters.

Compass Therapeutics, Inc. (CMPX) Historical Enterprise Value (quarterly & annually)

How has CMPX Enterprise Value performed in the past?

The mean historical Enterprise Value of Compass Therapeutics, Inc. over the last ten years is 298.02M. The current 176.46M Enterprise Value has changed 5.82% with respect to the historical average. Over the past ten years (40 quarters), CMPX's Enterprise Value was at its highest in in the December 2019 quarter at 509.09M. The Enterprise Value was at its lowest in in the June 2018 quarter at -7231.00.

Compass Therapeutics, Inc. (CMPX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Compass Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Compass Therapeutics, Inc. (CMPX) Average Enterprise Value

How has CMPX Enterprise Value performed in the past?

The current Enterprise Value of Compass Therapeutics, Inc. (CMPX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Compass Therapeutics, Inc. (CMPX) Enterprise Value vs. Peers

How is CMPX’s Enterprise Value compared to its peers?

Compass Therapeutics, Inc.’s Enterprise Value is less than IDEAYA Biosciences, Inc. (1.81B), less than AnaptysBio, Inc. (247.57M), less than MeiraGTx Holdings plc (446.07M), greater than Keros Therapeutics, Inc. (165.48M), greater than Homology Medicines, Inc. (-103303255.00), less than Monte Rosa Therapeutics, Inc. (351.25M), less than NewAmsterdam Pharma Company N.V. (2.35B), less than Inventiva S.A. (222.87M), less than Cullinan Oncology, Inc. (614.81M), greater than PepGen Inc. (108.11M), less than Tyra Biosciences, Inc. (647.39M), greater than Vigil Neuroscience, Inc. (34.91M), less than PureTech Health plc (313.18M), greater than Aerovate Therapeutics, Inc. (44.50M), less than Enliven Therapeutics, Inc. (1.03B), less than MoonLake Immunotherapeutics (2.95B), less than Structure Therapeutics Inc. (1.45B), less than Replimune Group, Inc. (904.39M), greater than Nuvectis Pharma, Inc. (72.67M), greater than Lyra Therapeutics, Inc. (22.80M), greater than Kronos Bio, Inc. (8.15M), less than Gossamer Bio, Inc. (366.39M),

Build a custom stock screener for Compass Therapeutics, Inc. (CMPX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Compass Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Compass Therapeutics, Inc. (CMPX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Compass Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.